YS

Yogesh Kumar Sareen - Profile

Yogesh Kumar Sareen, Cfo and Director, with 51 companies across 3 industries.

About Yogesh Kumar Sareen

Yogesh Kumar Sareen has 19 years in corporate governance. Holds Cfo and Director roles. Currently with 11 companies, including Max Healthcare Institute Limited and Crosslay Remedies Limited. Formerly with 40 companies, such as Alexis Multi-Speciality Hospital Private Limited and Escorts Heart And Super Speciality Institute Limited. Engaged in Healthcare, General Business and more.

Current Companies 11
Past Companies 40
Total Affiliations 51
Oldest Company Age 36
Companies Associated with Yogesh Kumar Sareen
Current Companies
Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions
Who is Yogesh Kumar Sareen?

Yogesh Kumar Sareen has 19 years in corporate governance. Holds Cfo and Director roles. Currently with 11 companies, including Max Healthcare Institute Limited and Crosslay Remedies Limited. Formerly with 40 companies, such as Alexis Multi-Speciality Hospital Private Limited and Escorts Heart And Super Speciality Institute Limited. Engaged in Healthcare, General Business and more.

What is Yogesh Kumar Sareen's role in current companies?

Yogesh Kumar Sareen is associated with 11 companies as Cfo and Director.

What industries does Yogesh Kumar Sareen specialize in?

Yogesh Kumar Sareen has expertise in Healthcare, General Business and other sectors.

How many years of experience does Yogesh Kumar Sareen have?

Yogesh Kumar Sareen has 19 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available